There is a card in circulation in Ireland that is more generous than a medical card, that cannot be means-tested, that cannot be reviewed, and that its holders keep for life. It pays for a GP of your choosing for any illness at all. It pays for dentures, varifocals, hearing aids, physiotherapy and as many chiropody appointments as your feet require, with no referral and no prior approval. Roughly 1,700 people in Ireland were made eligible for it, and most of them are now in their seventies.
It is called the Health (Amendment) Act card, and almost nobody outside the cohort has heard of it. More to the point, the official signposting that once led people to it has quietly fallen apart.
TL;DR
- The Health (Amendment) Act 1996 gives a lifetime card to people who contracted hepatitis C in Ireland from anti-D immunoglobulin, a blood transfusion, clotting factors or treatment for renal disease. About 1,700 people were infected.
- It is not a medical card. It covers GP care for all conditions, prescriptions with no per-item charge, dental, ophthalmic and aural treatment, physiotherapy, chiropody, home nursing and counselling for the cardholder and family.
- 78% of the people on Ireland’s national database for this cohort are women, most infected by contaminated anti-D given after childbirth in 1977-79 and 1991-94. Their average age was 63 when data collection ended in 2017.
- Treatment now cures over 95% of cases, but 28% of the chronically infected had developed cirrhosis, and anyone with cirrhosis needs six-monthly liver ultrasound for the rest of their life, cured or not.
- The HSE web pages that Citizens Information still links to for liaison officer contacts return “page not found”, and the official guide points to a website that no longer exists. The entitlement is intact; the directions are not.
Who holds this card, and why
In early 1994 it emerged that anti-D immunoglobulin, the injection given to rhesus-negative women after childbirth to protect future pregnancies, had been contaminated with hepatitis C. The Comptroller and Auditor General’s 2017 examination of the affair records that the contaminated product was administered to women in the State between 1977 and 1979, and again between 1991 and 1994. In February 1994 the Irish Blood Transfusion Service began screening every woman who had received anti-D between 1970 and 1994.
Others were infected by routes that attracted less public attention: whole blood transfusions, treatment for kidney disease, and the clotting factor concentrates given to people with haemophilia. The Lindsay Tribunal, which reported in 2002, found that 255 people with haemophilia had been infected with hepatitis C and 106 with HIV through blood products supplied by the State. By the twentieth anniversary of that report, the Irish Haemophilia Society recorded that 114 of them had died.
The Oireachtas responded in stages. The Health (Amendment) Act 1996 created the entitlement to free health services. The Hepatitis C Compensation Tribunal Act 1997 put the compensation scheme on a statutory footing, and the 2002 amending Act extended the compensation scheme to people infected with HIV by the same route. A further Act in 2006 established an insurance scheme. Taken together, the C&AG calculated that around €1.5 billion had been spent by the end of 2017, of which €1.17 billion was compensation and legal costs and €295 million was health services actually delivered.
What the card actually covers
Section 2 of the 1996 Act is short and unusually plain. A cardholder is entitled, without charge, to general practitioner medical and surgical services “in relation to all medical conditions”, from a doctor of their own choosing; to drugs, medicines and medical and surgical appliances; to home nursing and home support; to dental, ophthalmic and aural treatment and appliances; to counselling in respect of hepatitis C; and to whatever other services are prescribed.
That last clause has done a lot of work. The HSE’s own information guide, the 2020 edition of which is the most recent published, extends the list to physiotherapy, chiropody and podiatry, hearing tests and hearing aids, complementary therapies on referral, and vaccinations. Three details inside it are worth knowing and are routinely missed:
- No prescription charge. HAA cardholders are exempt from the per-item charge that medical card holders pay. Over a year of multiple medicines, that is not a trivial sum.
- Chiropody without gatekeeping. You may attend any qualified chiropodist or podiatrist, as often as you need, with no GP referral and no prior approval. For anyone in their seventies with diabetes or circulation problems, this is one of the most valuable lines in the document.
- A two-week onward referral. Where a consultant hepatologist refers a cardholder to another consultant in a public hospital, for the investigation or treatment of any condition, the first appointment is meant to be given within two weeks.
Counselling extends to immediate family, not just the cardholder. In a cohort where the infection arrived through a maternity ward and was carried silently for decades, that provision is doing more than it appears to.
Where the card stops
It is worth being straight about the limits, because the summaries circulating online tend to overpromise. On the primary care side the card really is open-ended: your GP treats you for anything, free. On the hospital side it is narrower. The HSE guide states that hospital services “not related in any way to Hepatitis C” are available on the same general terms as to any other member of the public, and that whether a condition is potentially hepatitis C-related is a clinical decision for the hepatologist. The card also does not reach into private hospitals at all.
In practice the hepatologist’s judgement is broad, because so much of what happens to a liver spreads outwards. But a cardholder who assumes the card covers a private hip replacement will be disappointed, and a cardholder who assumes it covers nothing beyond their liver is leaving a great deal on the table.
The cohort is in its seventies now
Ireland did something unusual with this group: it built a national database in 2004 and followed them properly. The final report, published by the Health Protection Surveillance Centre in July 2024, covers 1,322 people, a participation rate of 77%, with data to the end of 2017.
The profile is striking. Of the participants, 1,026 were women and 296 were men. Anti-D accounted for 61% of infections, transfusion or renal treatment for 26%, and clotting factors for 12%. The average age at last follow-up was 63, and the average interval between infection and that follow-up was 35 years.
That last figure is the one to sit with. The data closed at the end of 2017. A cohort whose average age was 63 then is, for those still living, into its seventies now. The women given anti-D in 1977 are approaching fifty years of living with the consequences of a single injection administered to protect a baby.
Being cured is not the end of the liver story
The clinical news is genuinely good. Direct-acting antivirals arrived in Ireland in late 2014 and changed everything. Among database participants treated with them, the cure rate was 99%. By the end of follow-up, 85% of living chronically infected participants had been treated and 95% had cleared the virus. Only 98 people in the whole database were recorded as alive and still infected.
But damage done over three decades does not reverse on cure. Among those who had ever been chronically infected, 28% had developed cirrhosis, at an average age of 58. Liver cancer was recorded in 7%, at an average age of 66, and almost three quarters of those who developed it had died by last follow-up. The report’s own conclusion is careful and should be read by every cardholder: patients with cirrhosis have a lower risk of liver failure and liver cancer once successfully treated, but “remain at elevated risk” and “require long-term monitoring for complications”.
What that monitoring looks like is not a mystery. The HSE’s own patient information states that if you have cirrhosis you should have ultrasound scans for liver cancer every six months. The European Association for the Study of the Liver published a position paper in 2024 devoted entirely to what follow-up should look like after hepatitis C is cured, precisely because cure and discharge are not the same thing.
The practical risk for a 74-year-old who was cured in 2016 is simple: the hepatology appointments taper off, the GP changes, nobody restates the surveillance plan, and a six-monthly scan quietly becomes a two-yearly one and then none. If you or a family member had cirrhosis before treatment, the question to ask at the next GP visit is not “am I cured” but “who is booking my scans, and when is the next one”.
The signposting has quietly rotted
Here is what prompted this piece. The Citizens Information page on hepatitis C and the HAA card is accurate, well written and was last edited on 30 October 2025. It tells readers to find the contact details of their local Hepatitis C Liaison Officer “on the HSE website”, and links to a specific HSE page three times.
That page returns “page not found”. So does the HSE’s page for the National Hepatitis C Treatment Programme. So does the page that once held the liaison officer list itself. The current HSE hepatitis C pages that replaced them are adapted from NHS content, carry advice about avoiding pregnancy during treatment, and make no mention of the Health (Amendment) Act, the card, or the State-acquired cohort at all.
The HSE’s own 2020 information guide, still live and still the definitive document, directs cardholders to the website of the Consultative Council on Hepatitis C. That domain no longer resolves to anything. Citizens Information and the guide both still publish a Lo-Call number for the insurance scheme beginning 1850, a prefix ComReg withdrew from service on 1 January 2022.
None of this changes the law. The entitlement is statutory, it is for life, and it cannot be reviewed away. But an entitlement you cannot find the door to is an entitlement in name only, and the people most affected are now at the age when they need it most and are least likely to chase a broken link through four redirects.
The insurance scheme almost nobody claimed
The 2006 Act created something quietly remarkable. People with State-acquired hepatitis C or HIV can take out life assurance, mortgage protection and travel insurance at the standard premium an uninfected person of the same age and gender would pay. The scheme administrator covers the loading, or underwrites the risk outright where a policy would otherwise be refused. Anyone holding an HAA card or a Tribunal award is automatically entitled to enter it; you apply for an eligibility certificate first.
The C&AG found that the HSE had expected to spend about €90 million over the life of the scheme. By 2017 it had spent approximately €9 million, and had no current estimate of what remained. That gap can be read two ways, and both are probably true: the medicine worked, and a great many eligible people never applied.
Travel insurance matters more at 75 than it did at 45. As we have written before about travel cover after 70, a declared liver history can make an ordinary fortnight abroad either unaffordable or uninsured. This scheme exists to solve exactly that problem, and it is sitting there unused.
What to check this month
If you hold an HAA card, or you are the son, daughter or carer of someone who does:
- Find the card. It is valid for life. If it has been lost, your Hepatitis C Liaison Officer will cancel the old number and issue a new one.
- Ask what you are not using. Chiropody, physiotherapy, hearing aids, dentures and counselling for family members are all covered and all routinely forgotten.
- Confirm the surveillance plan in writing. If there was cirrhosis before treatment, ask the GP or liver unit to state when the next ultrasound is due and who books it.
- Check the insurance scheme. If anyone has been refused or loaded on travel, life or mortgage cover, request an eligibility certificate.
- Review the medicines. A cured liver still metabolises differently, and a seventies medication list is longer than a fifties one. Ask the pharmacist for a review; it costs nothing under this card.
Useful contacts
These were verified as live at the time of writing. The HSE Hepatitis C National Office is at Stewarts Hospital, Mill Lane, Palmerstown, Dublin 20, telephone 01 620 1750. The Hepatitis C Insurance Scheme can be reached on 0818 200 114 or 01 620 1660. Transfusion Positive, which supports people infected through anti-D and transfusion, is on 01 234 3740. The Irish Haemophilia Society is on 01 657 9900, the Irish Kidney Association on 01 620 5306, and the Hepatitis C Partnership on 083 011 6110. Citizens Information’s page on the card remains the clearest public summary, and its phone service is 0818 07 4000.
The HSE set itself a target of making hepatitis C a rare disease in Ireland by 2026. On the clinical measure it has very nearly got there, which is a real achievement and worth saying plainly. The unfinished part of the job is smaller and less glamorous: making sure that the 1,700 people the State infected, now mostly in their seventies, can still find out what they are owed without needing a search engine and a stubborn streak.
At Críonna Health we write about the practical side of ageing in Ireland, including the entitlements that exist on paper but have stopped being advertised. If this applies to someone in your family, the single most useful thing you can do is ring the National Hepatitis C Office and ask for the liaison officer for your area.
This article is for general information and is not medical or legal advice. Entitlements and contact details change; confirm your own position with your GP, your Hepatitis C Liaison Officer or Citizens Information.
📷 Photo by Myriam Zilles on Unsplash
